The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease

Experimental Neurology

Volumn 145, Issue 1, 1997, Pages 295-302

  Sampson, Viola L ^a   Morrison, John H ^b   Vickers, James C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; PARVALBUMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0031149760     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6433     Document Type: Article

References (22)

1. Arai H., Emson P. C., Mountjoy C. Q., Carassco L. H., Heizmann C. W. Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia. Brain Res. 418:1987;164-169.
2. Blümcke I., Hof P. R., Morrison J. H., Celio M. R. Distribution of parvalbumin immunoreactivity in the visual cortex of old world monkeys and humans. J. Comp. Neurol. 301:1990;417-432.
3. Brion J. P., Resibois A. A subset of calretinin-positive neurons are abnormal in Alzheimer's disease. Acta Neuropathol. 88:1994;33-45.
4. Campbell M. J., Morrison J. H. Monoclonal antibody to neurofilament protein (SMI32) labels a subpopulation of pyramidal cells in the human and monkey neocortex. J. Comp. Neurol. 282:1989;191-205.
5. Condé F., Lund J. S., Jacobowitz D. M., Baimbridge K. G., Lewis D. A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: Distribution and morphology. J. Comp. Neurol. 341:1994;95-116.
6. Del Rio M. R., DeFelipe J. A study of SMI32-stained pyramidal cells, parvalbumin-immunoreactive chandelier cells, and presumptive thalamocortical axons in the human temporal neocortex. J. Comp. Neurol. 342:1994;389-408.
7. Ferrer I., Soriano E., Tunon T., Fonseca M., Guionnet N. Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J. Neurol. Sci. 106:1991;135-141.
8. Fonseca M., Soriano E. Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease. Brain Res. 691:1995;83-91.
9. Hof P. R., Cox K., Young W. G., Celio M. R., Rogers J., Morrison J. H. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 50:1991;451-462.
10. Hof P. R., Morrison J. H. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp. Neurol. 111:1991;293-301.
11. Hof P. R., Nimchinsky E. A. Regional distribution of neurofilament and calcium-binding proteins in the cingulate cortex of the macaque monkey. Cereb. Cortex. 2:1992;456-467.
12. Hof P. R., Nimchinsky E T., Celio M. R., Bouras C., Morrison J. H. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's Disease. Neurosci. Lett. 152:1993;145-149.
13. Hof P. R., Morrison J. H. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. Alzheimer Disease. 1994;Raven Press, New York. p. 197-229.
14. Hubbard B. M., Anderson J. M. A quantitative study of cerebral atrophy in old age and senile dementia. J. Neurol. Sci. 50:1981;135-145.
15. Pitkänen A., Amaral D. G. Parvalbumin-immunoreactive cells and fibers in the monkey temporal lobe: The amygdaloid complex. J. Comp. Neurol. 331:1993;14-36.
16. Seress L., Nitsch R., Leranth C. Calretinin immunoreactivity in the monkey hippocampal formation. I. Light and electron microscopic characteristics and co-localisation with other calcium-binding proteins. J. Neurosci. 55:1993;775-796.
17. Terry R. D., Masliah E., Hansen L. A. Structural basis of the cognitive alterations in Alzheimer disease. Terry R. D., Katzman R., Bick K. L. Alzheimer Disease. 1994;Raven Press, New York.
18. Vickers J. C., Costa M. The neurofilament triplet is present in distinct subpopulations of neurons in the central nervous system of the guinea-pig. Neuroscience. 49:1992;73-100.
19. Vickers J. C., Delacourte A., Morrison J. H. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res. 594:1992;273-278.
20. Vickers J. C., Riederer B. M., Marugg R. A., Bueé-Scherrer V., Bueé L., Delacourte A., Morrison J. H. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience. 62:1994a;1-13.
21. Vickers J. C., Morrison J. H., Friedrich V. L. Jr., Elder G. A., Perl D. P., Katz R. N., Lazzarini R. A. Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human mid-sized neurofilament subunit. J. Neurosci. 14:1994b;5603-5612.
22. Vickers J. C., Chin D., Edwards A-M., Sampson V., Harper C., Morrison J. H. Dystrophic neurite formation associated with age-related amyloid deposition in the neocortex: Clues to the genesis of neurofibrillary pathology. Exp. Neurol. 141:1996;1-11.